Decision Making in Big Pharma vs. Small Pharma

On many occasions, I have the opportunity to speak with leaders at small pharmaceutical and biotech companies. They always say, “We don’t operate like big pharma” or “I’m not interested in hearing the best practices from big pharma.” As a younger and less experienced leader from big pharma, I couldn’t fathom what they meant by[…]

5 Tips for Effective Portfolio Management

Imagine that you are Indiana Jones. A series of ancient doors lie before you. Behind one – unimaginable success, profitability, and reward. Behind the others – defeat, loss and failure. You have but a single key and too many possible doors – which to choose? Does this sound like your organization? This is the constant[…]

portfolio assessment

Laying the Foundation for Pharma Pipeline Decisions

It is well known that the days of Pharma thriving on blockbuster drugs are long gone. The drug development process is lengthy – currently spanning 15 years. And drugs on the market are coming off patent with few drugs to replace the significant revenue loss. As a result, measures to cut costs or just control[…]